Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer: A Post Hoc Analysis of the TOPAZ-1 Randomized

• by Do-Youn Oh, Aiwu Ruth He, Shukui Qin, Li-Tzong Chen, Takuji Okusaka, Rebecca Griffin, Julie Wang, Ioannis Xynos, Arndt Vogel, Juan W. Valle

• September 1, 2026

Roving Reporter Asks: How Is Cell and Gene Therapy Manufacturing Becoming More Scalable?

IBTV speaks with industry leaders at ASGCT 2026 about the technologies, processes, and manufacturing strategies helping advanced therapies progress toward commercial scale

• September 18, 2026

• 2 min

Large-cohort screening projects in seven regions of China demonstrate the efficacy of extended HPV genotyping in triaging HPV-positive women

• by Wenkui Dai, Yu Liu, Hui Du, Chunlei Guo, Di Wu, Xin Jiang, Shuai Cheng Li, Changzhong Li, Xinfeng Qu, Ruifang Wu

• September 14, 2026

Personalized Cancer Vaccine Linked to Three-Year Disease-Free Survival in Head and Neck Cancer

All 16 patients who received TG4050 after standard treatment remained disease-free, compared with 13 of 16 patients in the control group

• September 16, 2026

• 2 min